✦ LIBER ✦
P2-377: A phase 2, double-blind, placebo-controlled study to evaluate the safety, tolerability, and effect on cognitive function of AL-108 after 12 weeks of intranasal administration in subjects with mild cognitive impairment
✍ Scribed by Schmechel, Donald E.; Gerard, Gary; Vatakis, Nick G.; Harper, Linda; Ross, Joel S.; Bari, Mohammed; Walling, David; Stedman, Mary; Winston, Jaron L.; Morimoto, Bruce; Keith, Julian R.
- Book ID
- 123312914
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 62 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1552-5260
No coin nor oath required. For personal study only.